Rob Sarisky is President of Health and Life Science Advisors, a boutique firm providing corporate and business development support to life science companies. As an entrepreneurial executive and Board Member with over 30 years expertise in the pharmaceutical and biotechnology industry, Rob has contributed to the advancement of human health and drug launches through his leadership in drug discovery, external innovation, and corporate development. Prior to his current role, he served as Chief Business Officer and head of FORMA Ventures at FORMA Therapeutics (FMTX) in the Boston area. Previously to his entry into biotech, Rob was Vice President of Oncology Business Development and Licensing within Janssen Pharmaceuticals, a Johnson & Johnson company. He also held positions of Vice President of External Research and Early Development within Johnson & Johnson, head of Immunology Research at Centocor, and Director of Virology at GlaxoSmithKline Pharmaceuticals. Dr. Sarisky received his B.S. degree in Biology from the University of Scranton, a Ph.D. in Genetics from the Pennsylvania State University College of Medicine, completed his postdoctoral training at the Johns Hopkins School of Medicine, and holds an M.B.A. in Marketing from Lehigh University. He has authored more than 120 publications and patents and served on the Editorial Board for two scientific journals. He has been active in the academic community by previously serving on the University of Pennsylvania Executive Advisory Committee for the HHMI Graduate Training in Medical Sciences, the University of Miami Innovation Corporate Advisory Council, the University of North Carolina Innovation Transfer and Development Initiative, adjunct Professor for Drexel University School of Medicine and an Advisory Board member for Indiana University’s Biotechnology Program.